MedTrace Logo

Post-Market Clinical Follow-Up Study on the Safety and Performance of Ennovate® Complex

NCT05281757 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2026-04-15

No results posted yet for this study

Summary

Multicenter, multinational Post-Market Clinical Follow-Up (PMCF) study on the safety and performance of Ennovate® Complex - A prospective, pure data collection of all Ennovate® scoliosis patients in selected centers (not interventional, multicentric)

Conditions

  • Hyperkyphosis
  • Hyperlordosis
  • Congenital Scoliosis
  • Neuromuscular Scoliosis
  • Idiopathic Scoliosis

Interventions

DEVICE

posterior stabilization for the cervical spine

The Ennovate® Complex Spinal System is a posterior stabilization for the Complex and upper-thoracic spine. The implants are used for the posterior multisegmental correction and stabilization over all sections of the spine.

Sponsors & Collaborators

  • Raylytic GmbH

    collaborator INDUSTRY

  • Aesculap AG

    lead INDUSTRY

Principal Investigators

  • Mohd Hisam, Prof. Dr. · Hospital Universiti Kebangsaan Malaysia (HUKM)

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-18
Primary Completion
2026-04-30
Completion
2028-10-31

Countries

  • Czechia
  • Malaysia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05281757 on ClinicalTrials.gov